Medicine and Dentistry
Metastatic Colorectal Cancer
100%
Personalized Medicine
100%
Xenograft
100%
Malignant Neoplasm
57%
Immunity
42%
Cetuximab
28%
Bevacizumab
28%
T Cell
14%
Oxaliplatin
14%
Irinotecan
14%
Epidermal Growth Factor Receptor
14%
Disease Burden
14%
Medicine
14%
Immunoglobulin
14%
Next Generation Sequencing
14%
Cancer Cell
14%
Cancer Survival
14%
Immunology
14%
Indel Mutation
14%
Neoplasm
14%
Vasculotropin
14%
Tumour Heterogeneity
14%
Point Mutation
14%
B Cell
14%
Drug Resistance
14%
Folinic Acid
14%
Regorafenib
14%
T Lymphocyte Receptor
14%
Chemotherapy
14%
Biochemistry, Genetics and Molecular Biology
Genomics
100%
Immunity
60%
Bevacizumab
40%
Cetuximab
40%
Zebra Fish
40%
Drug Resistance
20%
Fish Model
20%
Chromosomal Rearrangement
20%
Tissue Culture
20%
Indel
20%
Animal Model
20%
Cancer Cell
20%
Clonal Evolution
20%
B Cell
20%
Regorafenib
20%
Genetics
20%
Vascular Endothelial Growth Factor
20%
T Cell Receptor
20%
Cancer Survival
20%
Disease Burden
20%
Intravenous Immunoglobulin
20%
Next Generation Sequencing
20%
Point Mutation
20%
Epidermal Growth Factor Receptor
20%
T Cell
20%
Pharmacology, Toxicology and Pharmaceutical Science
Metastatic Colorectal Cancer
100%
Malignant Neoplasm
71%
Zebra Fish
28%
Cetuximab
28%
Bevacizumab
28%
Neoplasm
28%
Folinic Acid
14%
Oxaliplatin
14%
Regorafenib
14%
T Lymphocyte Receptor
14%
Disease
14%
Irinotecan
14%
Chemotherapy
14%
Fish Model
14%
Epidermal Growth Factor Receptor
14%
Immunoglobulin
14%
Drug Resistance
14%
Vasculotropin
14%
Cancer Survival
14%